Prevention Sciences
Prevention Sciences
批准号:
9439157
负责人:
Michelle A Lally
金额:
$11.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AIDS preventionAcquired Immunodeficiency SyndromeAdministratorAdolescentAdvertisingAreaBathingBehavioralBehavioral MedicineBehavioral SciencesBiologicalBiological ProductsCaringChildCollaborationsCommunitiesCommunity ServicesConsultConsultationsDevelopmentDiseaseDoctor of PhilosophyEducationEventFacultyFrequenciesFundingGrantGrowthHIVHIV vaccineHuman immunodeficiency virus testIndividualInfectionInstitutional Review BoardsInternationalInterventionKnowledgeLawsLeadershipLongevityMeasuresMentorsMentorshipMethodologyMissionNational Institute of Mental HealthNewly DiagnosedOutcomePersonsPilot ProjectsPopulationPopulations at RiskPreventionPreventive MedicinePrimary PreventionPrisonerProstitutionPublic HealthRecruitment ActivityResearchResearch AssistantResearch DesignResearch PersonnelRhode IslandRiskScienceSecondary PreventionServicesStudentsTrainingTraining SupportTraining and EducationUnited States National Institutes of HealthVisionVulnerable Populationsbehavioral/social sciencebiobehaviordesignexperiencefight againstimprintmembermen who have sex with menmicrobicidemultidisciplinarynovelpre-exposure prophylaxispreventprogramsskillssuccesssymposiumyoung man
中文摘要
生物医学和行为科学的大胆整合将导致成功的艾滋病毒预防。我们的预防核心领导包括共同主任米歇尔·拉里,医学博士,理学硕士和拉里·布朗,医学博士。他们对艾滋病毒预防有着共同的热情,对艾滋病毒的新的"生物行为"方法有着共同的愿景。
预防Lally博士研究HIV疫苗和PrEP,Brown博士的丰富经验和
专长是行为科学额外的核心教师,所有一流的,每个致力于
生物医学和行为科学的结合,包括迈克尔凯里,博士,中心主任,
Lifespan的行为和预防医学,Don Operario,博士,研究生项目主任
行为和社会科学干预,布朗计划在公共卫生,凯特莫罗,博士
(杀菌剂可接受性)。Curt Beckwith,医学博士(囚犯和其他人中的艾滋病毒检测和治疗)
Steve Hong,MD(国际艾滋病一级和二级预防),以及
Kenneth Mayer,医学博士(广泛的艾滋病毒预防经验和专业知识)。印有"B & B"的红丝带是
我们的核心的标志,这是有效地促进生物医学和行为品牌,我们的
预防核心。我们的目标是提供艾滋病毒预防研究人员(学生/初级研究人员/
经验丰富的调查员)提供咨询和指导、教育和培训以及支持服务
这是一贯的包容性的生物医学和行为科学。目标将通过
有效宣传我们的服务、个人咨询和对初级研究人员的持续指导,
教育和培训(每周、每月、每季度或每年)以及社区合作。
预期成果是,在我们的国家中,
调查人员,核心用户数量持续增长,核心服务使用频率增加,
以及明确结合生物医学和生物医学的个人预防项目数量的稳步增加。
和行为科学将对成果进行跟踪和衡量,并对我们的
采取必要的措施,以确保取得成果。
英文摘要
Bold integration of biomedical and behavioral science will result in successful HIV Prevention. Our Prevention Core leadership includes Co-Directors Michelle Lally, MD, MSc and Larry Brown, MD. With a shared passion for HIV prevention and a shared vision of novel "biobehavioral" approaches to HIV
prevention. Dr. Lally investigates HIV Vaccines and PrEP, and Dr. Brown's extensive experience and
expertise is in behavioral science. Additional Core Faculty, all superb and each committed to the
combination of biomedical and behavioral science, include Michael Carey, PhD, Director of Centers for
Behavioral and Preventive Medicine at Lifespan, Don Operario, PhD, Director of Graduate Program in
Behavioral and Social Sciences Intervention, Brown Program in Public Health, Kate Morrow, PhD
(microbicide acceptability). Curt Beckwith, MD (HIV testing and treatment among prisoners and other
marginalized populations), Steve Hong, MD (international HIV primary and secondary prevention), and
Kenneth Mayer, MD (broad HIV prevention experience and expertise). A red ribbon imprinted with "B & B" is
our Core's logo, which has been effective at promoting the Biomedical & Behavioral branding of our
Prevention Core. Our Aims are to provide HIV prevention researchers (students /junior investigators /
experienced investigators) with consultation and mentorship, education and training, and support services
that are consistently inclusive of both biomedical and behavioral science. Aims will be achieved through
effective advertising of our services, individual consultations and ongoing mentorship of junior investigators,
education and training (on a weekly, monthly, quarterly, or annual basis), and community collaboration.
Expected outcomes are sustained and increased funding for research related to HIV prevention among our
investigators, continued growth in the number of Core users, increased frequency of use of Core services,
and a steady increase in the number of individual prevention projects that cleariy incorporate both biomedical
and behavioral science. Outcomes will be tracked and measured, and adjustments will be made to our
approaches as necessary to assure that outcomes are achieved.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV/INFECTIOUS DISEASE TEST/TREATMENT IN SUBSTANCE ABUSE
-
批准号:6211905
-
项目类别:
-
资助金额:$13.42万
-
财政年份:2000
-
负责人:Michelle A Lally
-
依托单位:
HIV RAPID TESTING AMONG SUBSTANCE ABUSERS
-
批准号:6392906
-
项目类别:
-
资助金额:$7.1万
-
财政年份:2000
-
负责人:Michelle A Lally
-
依托单位:
HIV/INFECTIOUS DISEASE TEST/TREATMENT IN SUBSTANCE ABUSE
-
批准号:6661867
-
项目类别:
-
资助金额:$13.71万
-
财政年份:2000
-
负责人:Michelle A Lally
-
依托单位:
HIV/INFECTIOUS DISEASE TEST/TREATMENT IN SUBSTANCE ABUSE
-
批准号:6402531
-
项目类别:
-
资助金额:$13.64万
-
财政年份:2000
-
负责人:Michelle A Lally
-
依托单位:
HIV RAPID TESTING AMONG SUBSTANCE ABUSERS
-
批准号:6283554
-
项目类别:
-
资助金额:$6.96万
-
财政年份:2000
-
负责人:Michelle A Lally
-
依托单位:
HIV/INFECTIOUS DISEASE TEST/TREATMENT IN SUBSTANCE ABUSE
-
批准号:6801580
-
项目类别:
-
资助金额:$14.38万
-
财政年份:2000
-
负责人:Michelle A Lally
-
依托单位:
HIV/INFECTIOUS DISEASE TEST/TREATMENT IN SUBSTANCE ABUSE
-
批准号:6523131
-
项目类别:
-
资助金额:$13.49万
-
财政年份:2000
-
负责人:Michelle A Lally
-
依托单位:
海外基金